Market Cap 1.59B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 6,466,500
Avg Vol 5,947,018
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 85%
Beta 1.02
Analysts Strong Sell
Price Target $10.43

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Stocktradesmoon
Stocktradesmoon May. 25 at 8:28 PM
$ABCL I have $ABCL fomo and I’m afraid it just gaps up hard this week and none of you get an entry. Might add pre market tonight.
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 8:11 PM
$ABCL Destined for greatness. Look at that volume…
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 6:23 PM
$ABCL Went from 9.5% to 14.79% this morning. It’s getting into painful territory for shorts, and if the price keeps going up, the 44m+ short interest (on a shrinking float, if institutions are taking positions) are going to be in real trouble. Very interesting!
0 · Reply
Stockingtrade
Stockingtrade May. 25 at 2:07 PM
$ABCL Borrow rate is now 14.79% - shorts getting squeezed!!!
1 · Reply
Estimize
Estimize May. 25 at 11:09 AM
Wall St is expecting -0.14 EPS for $ABCL Q2 [Reporting 08/06 AMC] http://www.estimize.com/intro/abcl?chart=historical&metric_name=eps&utm_c
0 · Reply
tradersunion353
tradersunion353 May. 25 at 1:22 AM
$ABCL overhyped junkie new script from few married to ABCL folks ” we no longer care if stock drops after phase 2 data” we love this company these clowns should stop trading ASAP especially one one paid artist called jack prescott - this guy has beeb pump this scam left and right
1 · Reply
PolarBear1
PolarBear1 May. 24 at 9:15 PM
$ABCL https://www.pnas.org/doi/10.1073/pnas.1211517109
0 · Reply
PolarBear1
PolarBear1 May. 24 at 9:08 PM
$ABCL https://www.reddit.com/r/ABCL/comments/1sp5uln/why_abcls_abcl635_phase_2_readouts_will_be/ https://www.reddit.com/r/ABCL/comments/1tdjpst/why_abcl635_has_a_strong_chance_of_positive_phase/
0 · Reply
PhotonicDigger
PhotonicDigger May. 24 at 4:22 PM
$ABCL remains in a key technical phase with the 200WMA acting as an expected resistance zone, consistent with prior wave structure behavior. A sustained move above $5.30 would shift focus toward higher resistance near $6.50, with a potential extension into a broader upside range if momentum continues. Trend continuation depends on reclaiming key moving average levels and confirming breakout structure.
0 · Reply
Ckkung71
Ckkung71 May. 24 at 12:32 PM
$ABCL Positions advertised so far in May 2026: • QA Operations Manager (Vancouver) • Manager, QC Systems (×2) • Specialist, QC Systems (×2) • In Vivo Specialist, Operations (Vancouver) • In Vivo Specialist, Research (Vancouver) • Gestionnaire des études cliniques internationales (Montreal)
0 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 13 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Q1 Earnings Call Highlights

May 11, 2026, 7:08 PM EDT - 13 days ago

AbCellera Biologics Q1 Earnings Call Highlights


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 20 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 26 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 26 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 6 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 7 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 7 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Stocktradesmoon
Stocktradesmoon May. 25 at 8:28 PM
$ABCL I have $ABCL fomo and I’m afraid it just gaps up hard this week and none of you get an entry. Might add pre market tonight.
1 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 8:11 PM
$ABCL Destined for greatness. Look at that volume…
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 25 at 6:23 PM
$ABCL Went from 9.5% to 14.79% this morning. It’s getting into painful territory for shorts, and if the price keeps going up, the 44m+ short interest (on a shrinking float, if institutions are taking positions) are going to be in real trouble. Very interesting!
0 · Reply
Stockingtrade
Stockingtrade May. 25 at 2:07 PM
$ABCL Borrow rate is now 14.79% - shorts getting squeezed!!!
1 · Reply
Estimize
Estimize May. 25 at 11:09 AM
Wall St is expecting -0.14 EPS for $ABCL Q2 [Reporting 08/06 AMC] http://www.estimize.com/intro/abcl?chart=historical&metric_name=eps&utm_c
0 · Reply
tradersunion353
tradersunion353 May. 25 at 1:22 AM
$ABCL overhyped junkie new script from few married to ABCL folks ” we no longer care if stock drops after phase 2 data” we love this company these clowns should stop trading ASAP especially one one paid artist called jack prescott - this guy has beeb pump this scam left and right
1 · Reply
PolarBear1
PolarBear1 May. 24 at 9:15 PM
$ABCL https://www.pnas.org/doi/10.1073/pnas.1211517109
0 · Reply
PolarBear1
PolarBear1 May. 24 at 9:08 PM
$ABCL https://www.reddit.com/r/ABCL/comments/1sp5uln/why_abcls_abcl635_phase_2_readouts_will_be/ https://www.reddit.com/r/ABCL/comments/1tdjpst/why_abcl635_has_a_strong_chance_of_positive_phase/
0 · Reply
PhotonicDigger
PhotonicDigger May. 24 at 4:22 PM
$ABCL remains in a key technical phase with the 200WMA acting as an expected resistance zone, consistent with prior wave structure behavior. A sustained move above $5.30 would shift focus toward higher resistance near $6.50, with a potential extension into a broader upside range if momentum continues. Trend continuation depends on reclaiming key moving average levels and confirming breakout structure.
0 · Reply
Ckkung71
Ckkung71 May. 24 at 12:32 PM
$ABCL Positions advertised so far in May 2026: • QA Operations Manager (Vancouver) • Manager, QC Systems (×2) • Specialist, QC Systems (×2) • In Vivo Specialist, Operations (Vancouver) • In Vivo Specialist, Research (Vancouver) • Gestionnaire des études cliniques internationales (Montreal)
0 · Reply
PolarBear1
PolarBear1 May. 23 at 5:33 AM
1 · Reply
Tahadicaprio
Tahadicaprio May. 23 at 12:59 AM
0 · Reply
Tahadicaprio
Tahadicaprio May. 23 at 12:49 AM
━━━━━━━━━━━━━━ 📈 NEXT WEEK WATCHLIST ━━━━━━━━━━━━━━ 🥇 $IBRX – 8.40$ 🥈 $ABCL – 6.20$ 🥉 $NNOX –2.07$ 🎰 $QNTM –12$ ⚠️ $TE –11$
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 22 at 11:11 PM
$ABCL I am reminded of the phrase “Can’t see the forest for the trees”. I’m invested in what I believe will be golden egg laying goose. Not a single molecule.
0 · Reply
Cassek86
Cassek86 May. 22 at 11:06 PM
$ABCL You really have too much time on your hands, don't you? Get a hobby.
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 22 at 11:00 PM
$ABCL Carl Hansen profile pictures now… LFG 🤣👍🏻
0 · Reply
tradersunion353
tradersunion353 May. 22 at 10:46 PM
$ABCL What are clowns celebrating for... hello this overhyped stock is down by 83% for last 5 years, On phase 1 data this POS dropped 30% No news is moving is POS...
0 · Reply
capitalthinktank
capitalthinktank May. 22 at 9:52 PM
$ABCL is still being priced like a traditional biotech company—at least until it is no longer treated that way. This is not a prediction or a forecast. But if that moment ever arrives, there will likely be a wave of “experts” and “specialists” loudly arguing that it is overvalued and labeling it a meme stock, using conventional valuation models to justify where the price should be. My approach remains a 3–5 year horizon, and I will continue holding as long as the underlying thesis remains intact. They might even be right in the short term, and the stock could pull back. That doesn’t change my perspective. I consider myself an owner, not a trader. Markets move through cycles of undervaluation and overvaluation, and I will stay focused on the long term.
0 · Reply
8008track
8008track May. 22 at 9:13 PM
$ABCL what a week gang. Have a great weekend to all the longs and the secret longs too!
0 · Reply
tradersunion353
tradersunion353 May. 22 at 7:14 PM
$ABCL a scam will be a scam overhyped junk is about to close RED the biggest overhyped probably paid by insiders to pump this POS
1 · Reply
Quadruple_Double
Quadruple_Double May. 22 at 7:08 PM
$ABCL another turd spamming the forum with nothing of value.
0 · Reply
tradersunion353
tradersunion353 May. 22 at 6:47 PM
$ABCL junkie pos badly wants to close RED except overhype on x this pos have not delivered any significant returns for the investors
0 · Reply